An evaluation of the effect of aspartame on weight loss.
Study Goal
The researchers aimed to determine whether adding aspartame-sweetened foods and beverages to a low-fat, hypocaloric diet improves compliance and enhances weight loss.
Results Summary
Males achieved clinically significant weight loss in both groups, while females lost more weight in the aspartame-supplemented group (16.5 lb vs. 12.8 lb). Both groups showed improvements in sleep, energy, physical activity, and well-being.
Population
59 obese men and women (130-225% of ideal body weight).
Effective Dosage
Not specified
Duration
12 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Balanced Deficit Diet (BDD) | decrease | weight | obese (130-225% of ideal body weight), free living men | greater than 23 lb | achieved a clinically significant weight loss | #1 |
Balanced Deficit Diet (BDD) supplemented with aspartame | decrease | weight | obese (130-225% of ideal body weight), free living men | greater than 23 lb | achieved a clinically significant weight loss | #2 |
Balanced Deficit Diet (BDD) | decrease | weight | obese (130-225% of ideal body weight), free living women | 12.8 lb | lost an average of | #3 |
Balanced Deficit Diet (BDD) supplemented with aspartame | decrease | weight | obese (130-225% of ideal body weight), free living women | 16.5 lb | lost an average of | #4 |
Balanced Deficit Diet (BDD) | increase | sleep | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #5 |
Balanced Deficit Diet (BDD) | increase | general energy level | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #6 |
Balanced Deficit Diet (BDD) | increase | level of physical activity | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #7 |
Balanced Deficit Diet (BDD) | increase | feeling of well-being | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #8 |
Balanced Deficit Diet (BDD) supplemented with aspartame | increase | sleep | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #9 |
Balanced Deficit Diet (BDD) supplemented with aspartame | increase | general energy level | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #10 |
Balanced Deficit Diet (BDD) supplemented with aspartame | increase | level of physical activity | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #11 |
Balanced Deficit Diet (BDD) supplemented with aspartame | increase | feeling of well-being | obese (130-225% of ideal body weight), free living men and women | - | showed clinically meaningful improvement | #12 |
This study explores whether the addition of aspartame-sweetened foods and beverages to a low fat, hypocaloric diet enhances compliance and resulting weight loss. Fifty-nine obese (130-225% of ideal body weight), free living men and women were randomly assigned to either a Balanced Deficit Diet (BDD) or a BDD supplemented with aspartame. Over a 12-week weight loss period, volunteers attended weekly support group meetings including behavior modification training and exercise instruction. Males achieved a clinically significant weight loss (greater than 23 lb) in both study groups, while females lost an average of 12.8 lb in the control group vs. 16.5 lb in the experimental group. In both treatment groups, sleep, general energy level, level of physical activity, and feeling of well-being showed clinically meaningful improvement. This study suggests possible advantages to supplementing a BDD with aspartame-sweetened foods as part of a multidisciplinary weight loss program. The small sample size prohibits definitive conclusions but does provide the protocol for a larger, outpatient clinical trial.